Immunohistochemical study of annexin V expression in placentae of preeclampsia

Gynecol Obstet Invest. 2000;49(1):17-23. doi: 10.1159/000010206.

Abstract

We investigated the clinical significance of annexin V in the placentae with preeclampsia and found: (1) annexin V was detected on trophoblasts in the placentae and the staining intensity of annexin V in the placentae from such patients was reduced when compared to normal placentae; (2) as expression of annexin V was reduced, the gestosis index from patients with preeclampsia was elevated and the standard deviation value in the infant's standard weight was decreased; plasma level of the fibrin degradation products and thrombin-antithrombin III complex from patients were elevated as the expression of anexin V was reduced. These results suggest that the reduced expression of annexin V in the placentae from patients with preeclampsia may lead to a hypercoagulable state in the intervillous space and may be associated with the development of intrauterine growth restriction.

MeSH terms

  • Annexin A5 / analysis*
  • Antithrombin III / analysis
  • Female
  • Fetal Growth Retardation / metabolism
  • Fibrin Fibrinogen Degradation Products / analysis
  • Gestational Age
  • Humans
  • Immunohistochemistry*
  • Peptide Hydrolases / analysis
  • Placenta / chemistry*
  • Pre-Eclampsia / metabolism*
  • Pregnancy

Substances

  • Annexin A5
  • Fibrin Fibrinogen Degradation Products
  • antithrombin III-protease complex
  • Antithrombin III
  • Peptide Hydrolases